Atlas Trials

Efficacy and Safety of Dual Therapy for Helicobacter Pylori Eradication

Clinical trial NCT05469685 · COMPLETED

Trial details

NCT number
NCT05469685
Sponsor
Nanjing First Hospital, Nanjing Medical University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Helicobacter Pylori Infection
Start date
2022-08-01
Primary completion
2023-08-31
Enrollment
914

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.